Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_assertion description "[We found that individuals homozygous for the XPG/ERCC5 -72C/T promoter polymorphism had a significant reduction in risk, for prostate cancer (OR=0.12; 95% CI=0.03-0.48).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_assertion evidence source_evidence_literature NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_assertion SIO_000772 18026184 NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_assertion wasDerivedFrom befree-20140225 NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_assertion wasGeneratedBy ECO_0000203 NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP251830.RAHxJlgpsheGeFjRvM9GYFJ8VNeDh64U_7c_NyHf2_8iA130_provenance.